AKYA - Akoya Biosciences, Inc.
1.31
0.010 0.763%
Share volume: 85,915
Last Updated: 04-28-2025
Measuring And Control Equipment/Lab Analytical Instruments:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$1.30
0.01
0.01%
Fundamental analysis
25%
Profitability
0%
Dept financing
20%
Liquidity
65%
Performance
40%
Performance
5 Days
3.15%
1 Month
-5.76%
3 Months
-56.33%
6 Months
-54.04%
1 Year
-66.06%
2 Year
-81.26%
Key data
Stock price
$1.31
DAY RANGE
$1.28 - $1.38
52 WEEK RANGE
$1.01 - $4.65
52 WEEK CHANGE
-$65.71
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-12-2025
Company detail

CEO: Brian McKelligon
Region: US
Website: akoyabio.com
Employees: 90
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Measuring And Control Equipment/Lab Analytical Instruments
Sector: Manufacturing
Region: US
Website: akoyabio.com
Employees: 90
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Measuring And Control Equipment/Lab Analytical Instruments
Sector: Manufacturing
Akoya Biosciences provides spatial biology solutions focused on transforming discovery and clinical research. It offers single-cell resolution with spatial context that provides a wealth of information to visualize tissue organization and disease pathology on a molecular level. The company also provides PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition.
Recent news
